10 Best Growth Stocks to Buy According to Billionaires
The stock market has been on a rollercoaster ride for the past few weeks as the sentiment has quickly shifted from post-election bullishness to being priced in for a slow-down or a recession.
Ascendis Pharma A/S (ASND)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | RA Capital Management Peter Kolchinsky | 10,112,744 | $1,392,221,466 | +5% | 18.52% |
| 2. | VenBio Select Advisor Kurt Von Emster | 5,103,055 | $702,537,582 | +3% | 9.93% |
| 3. | Citadel Investment Group Ken Griffin | 895,984 | $123,350,117 | +35% | 0.02% |
| 4. | Vestal Point Capital Ryan Wilder | 520,000 | $71,588,400 | +108% | 4.24% |
| 5. | Point72 Asset Management Steve Cohen | 503,669 | $69,340,068 | +2% | 0.15% |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 5,335 | $831,514 | 0.1% | |
| 2. | 530,000 | $628,135 | 0.09% | |
| 3. | 520,000 | $580,269 | 0.01% | |
| 4. | 1,386 | $216,016 | 0% | |
| 5. | 161,000 | $190,811 | 0.01% |
News See All
Ascendis Pharma A/S (NASDAQ:ASND) Q4 2024 Earnings Call Transcript
Operator: Good day and thank you for standing by. Welcome to the Fourth Quarter and Full Year 2024 Ascendis Pharma Earnings Conference Call. At this time, all participants are in a listen-only mode.
12 High Growth International Stocks to Invest in Now
On January 15, Jurrien Timmer, Director of Global Macro at Fidelity Management & Research Company shared his outlook for 2025.
Ascendis Pharma A/S (NASDAQ:ASND) Q3 2024 Earnings Call Transcript
Operator: Good day, and thank you for standing by. Welcome to the Ascendis Pharma Third Quarter Earnings Call. At this time all participants are in a listen-only mode.
10 Largest Biotech Hedge Funds and Their Top Stock Picks
The ability to successfully make money through investment requires deep thinking and analysis.
Ascendis Pharma A/S (NASDAQ:ASND) Q2 2024 Earnings Call Transcript
Operator: Hello. Thank you for standing by. Welcome to Ascendis Pharma's Second Quarter 2024 Earnings Conference Call. At this time, all participants are in a listen-only mode.
Ascendis Pharma A/S (ASND) Stock Soared on Unexpected Demand
TimesSquare Capital Management, an equity investment management company, released its “U.S. Small Cap Growth Strategy” first-quarter 2024 investor letter.
Ascendis Pharma A/S (NASDAQ:ASND) Q1 2024 Earnings Call Transcript
Operator: Good day, and welcome to the Q1 2024 Ascendis Pharma Earnings Conference Call. At this time, all participants are in a listen-only mode.
5 Fastest Growing Health Tech Companies in the World
In this article, we will be taking a look at the 5 fastest growing health tech companies in the world.
Ascendis Pharma A/S (ASND) Rose on Positive Trial Results
TimesSquare Capital Management, an equity investment management company, released its “U.S. Small Cap Growth Strategy” fourth-quarter investor letter. A copy of the same can be downloaded here.
Billionaire Hedge Funds
